2024-10-26 - Analysis Report
## CVS Health Corp (CVS) Stock Analysis

**Company Overview:** CVS Health Corp is a leading healthcare company that operates pharmacies, retail stores, and provides pharmacy benefits management services. 

**1. Performance vs. S&P 500:**

* **Cumulative Return:** CVS: -37.68%, VOO (S&P 500): 135.48%.
* **Performance Gap:** CVS has significantly underperformed the S&P 500, with a cumulative return difference of **-173.16%**. This places CVS in the **bottom 19th percentile** compared to the S&P 500's historical performance range.

**2. Recent Price Movements:**

* **Closing Price:** 56.12 (Last Market: 56.72)
* **Moving Averages:**
    * 5-day: 57.77
    * 20-day: 62.84
    * 60-day: 59.47
* **Analysis:** CVS is trading below all three moving averages, suggesting potential downward momentum. 

**3. Technical Indicators:**

* **RSI:** 21.95 (Oversold)
* **PPO:** -2.05 (Sell Signal)
* **Relative Divergence:** 0.19 (+): Short-term upward movement 
* **Expected Return:** 0.0% - This suggests that over the long term (2 years or more), CVS is expected to yield similar returns to the S&P 500. 

**4. Recent Earnings and Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

* **Most recent earnings:** CVS exceeded analysts' expectations for the quarter ended August 7th, 2024, reporting EPS of $1.83 against an expected $1.73. 
* **Overall:** CVS has a mixed earnings track record with some quarters exceeding expectations and others falling short. The company faces pressure from rising healthcare costs and competition.

**5. News and Recent Issues:**

* **Recent Earnings Release:** CVS released its Q2 2024 earnings on August 7th, 2024, exceeding expectations and reporting strong revenue growth. 
* **Analyst Opinions:** Analysts remain cautiously optimistic about CVS's future prospects, citing the company's strong market position and growth opportunities in healthcare services. However, concerns remain regarding the potential for margin compression and rising competition.
* **Market Outlook:**  The stock market outlook for CVS is relatively neutral. While the company is well-positioned in the healthcare sector, it faces challenges from increasing competition and inflationary pressures.  

**6. Overall Analysis:**

CVS Health Corp is currently facing challenges and has underperformed the market significantly.  While the company recently exceeded earnings expectations, the stock is trading below its moving averages, indicating potential downward momentum. Technical indicators suggest a sell signal and an oversold condition. Although long-term expected returns are comparable to the S&P 500, investors should consider the recent market trends and current macroeconomic environment before making investment decisions. 
